Effectiveness, Satisfaction, and Usability of Virtual Reality in the Management of Postoperative Pain in Patients Undergoing Knee Arthroplasty
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of using virtual reality glasses to reduce the need for rescue analgesia in patients with acute postoperative pain after knee arthroplasty. The main questions it aims to answer are:
- What is the impact of virtual reality use on postoperative pain perception as measured by the Visual Analogue Scale (VAS)?
- What potential adverse effects are associated with the use of virtual reality in the postoperative context?
- What is the level of satisfaction and acceptance of virtual reality as a complementary strategy for pain management?
- How does virtual reality influence quality of life and psychosocial variables in patients with acute postoperative pain after knee arthroplasty?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2025
CompletedFirst Posted
Study publicly available on registry
December 16, 2025
CompletedStudy Start
First participant enrolled
December 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
ExpectedDecember 16, 2025
December 1, 2025
3 days
December 3, 2025
December 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity (VAS)
Pain intensity is assessed using a 100-mm Visual Analogue Scale (VAS), ranging from "no pain" (0 mm, left anchor) to "worst imaginable pain" (100 mm, right anchor). Higher scores indicate greater pain intensity.
Day 0 (day of intervention): pain measured at arrival to the ward and during three shifts (morning, afternoon, next-day morning), pre- and post conventional analgesia. If VR is used, pain is also measured immediately before and after each VR session.
Secondary Outcomes (7)
Sociodemographic variables
Baseline
Analgesic medication use
From immediate postoperative period to 48 hours post-intervention.
Adverse events
Throughout the intervention period and up to 48 hours post-intervention.
Satisfaction, Acceptability, and Perceived Safety (SEQ)
Immediately post-intervention
Health-Related Quality of Life (EQ-5D-5L)
Baseline and 1-month follow-up during outpatient visit
- +2 more secondary outcomes
Study Arms (3)
CONTROL
NO INTERVENTIONCONVENTIONAL TREATMENT
EXPERIMENTAL
EXPERIMENTALVR GAMES
PLACEBO
PLACEBO COMPARATORVR VIDEOS 360º
Interventions
Interactive VR Games: Participants use Meta Quest 3 head-mounted displays running a custom-developed VR application designed to elicit upper-limb and trunk movements. The application includes multiple structured scenarios: * Scenario 1 (Painting): Participants perform arm movements using handheld controllers to interact with a virtual painting environment. * Scenario 2 (Greenhouse): Participants move the arm to attract a butterfly, guide it toward a flower, and complete the assigned interaction task. * Scenario 3 (Aquarium): Participants perform bilateral arm movements to pop virtual bubbles. Immersive 360° Videos:Participants use Meta Quest 3 head-mounted displays to view immersive 360° relaxing videos (e.g., natural landscapes accompanied by calming background music).
Eligibility Criteria
You may qualify if:
- Adults ≥18 years of age, both sexes
- Scheduled unilateral knee arthroplasty
- Adequate cognitive and functional capacity to use virtual reality
- Signed informed consent
You may not qualify if:
- Neurological or psychiatric disorders (history of epilepsy, seizures, psychosis, schizophrenia, claustrophobia, tremor, rigidity)
- Significant visual or hearing impairments that hinder VR use
- Physical or motor limitations preventing the use of VR headsets or maintaining the required posture
- Score ≥4 on the 4AT delirium screening tool
- Pregnancy
- Recreational drug or alcohol use
- Inability to complete the intervention protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Castilla-La Manchacollaborator
- Hospital Universitario del Surestecollaborator
- Universidad Francisco de Vitorialead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2025
First Posted
December 16, 2025
Study Start
December 27, 2025
Primary Completion
December 30, 2025
Study Completion (Estimated)
December 30, 2026
Last Updated
December 16, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share